Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,337 INR | +0.35% |
|
+7.94% | +23.35% |
Jun. 27 | Aurobindo Pharma Arm's Injectable Facility Gets 'Voluntary Action Indicated' Classification from US FDA | MT |
Jun. 24 | INDIA STOCKS-Financials weigh on Indian shares; small-, mid-caps fall | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.35% | 9.35B | |
+59.97% | 840B | |
+37.89% | 621B | |
-6.18% | 354B | |
+15.61% | 319B | |
+8.44% | 297B | |
+13.25% | 237B | |
+14.54% | 221B | |
+0.82% | 220B | |
+9.68% | 169B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- US FDA Completes Inspection of Aurobindo Pharma's Injectibles Unit